CD274 and cancer: It remains to be deciphered whether the therapeutic outcome of PD-1 blockade is different between patients with oncogenic PD-L1 expression versus immunogenic PD-L1 expression, in which PD-L1 is expressed on cancer cells and immune cells, respectively.